RGNXClinical Trials•prnewswire•
REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy
Sentiment:Positive (70)
Summary
A pivotal Phase IIb/III clinical trial using suprachoroidal delivery for treatment of diabetic retinopathy will be initiated New Phase II ALTITUDE® trial data demonstrate a durable safety and efficacy profile observed through two years with a single, in-office injection of surabgene...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 7, 2025 by prnewswire